These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31486039)

  • 1. Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.
    Pol JG; Bridle BW; Lichty BD
    Methods Mol Biol; 2020; 2058():191-211. PubMed ID: 31486039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models.
    Veinalde R
    Methods Mol Biol; 2020; 2058():213-227. PubMed ID: 31486040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
    Das K; Belnoue E; Rossi M; Hofer T; Danklmaier S; Nolden T; Schreiber LM; Angerer K; Kimpel J; Hoegler S; Spiesschaert B; Kenner L; von Laer D; Elbers K; Derouazi M; Wollmann G
    Nat Commun; 2021 Aug; 12(1):5195. PubMed ID: 34465781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.
    Speck T; Heidbuechel JPW; Veinalde R; Jaeger D; von Kalle C; Ball CR; Ungerechts G; Engeland CE
    Clin Cancer Res; 2018 May; 24(9):2128-2137. PubMed ID: 29437789
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.
    Roy DG; Geoffroy K; Marguerie M; Khan ST; Martin NT; Kmiecik J; Bobbala D; Aitken AS; de Souza CT; Stephenson KB; Lichty BD; Auer RC; Stojdl DF; Bell JC; Bourgeois-Daigneault MC
    Nat Commun; 2021 May; 12(1):2626. PubMed ID: 33976179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.
    Lemay CG; Rintoul JL; Kus A; Paterson JM; Garcia V; Falls TJ; Ferreira L; Bridle BW; Conrad DP; Tang VA; Diallo JS; Arulanandam R; Le Boeuf F; Garson K; Vanderhyden BC; Stojdl DF; Lichty BD; Atkins HL; Parato KA; Bell JC; Auer RC
    Mol Ther; 2012 Sep; 20(9):1791-9. PubMed ID: 22760544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity.
    Granot T; Yamanashi Y; Meruelo D
    Mol Ther; 2014 Jan; 22(1):112-22. PubMed ID: 24025748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arming oncolytic viruses to leverage antitumor immunity.
    de Gruijl TD; Janssen AB; van Beusechem VW
    Expert Opin Biol Ther; 2015 Jul; 15(7):959-71. PubMed ID: 25959450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
    Chen X; Zhao J; Yue S; Li Z; Duan X; Lin Y; Yang Y; He J; Gao L; Pan Z; Yang X; Su X; Huang M; Li X; Zhao Y; Zhang X; Li Z; Hu L; Tang J; Hao Y; Tian Q; Wang Y; Xu L; Huang Q; Cao Y; Chen Y; Zhu B; Li Y; Bai F; Zhang G; Ye L
    Nat Cancer; 2024 Jul; 5(7):1063-1081. PubMed ID: 38609488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.
    Atherton MJ; Stephenson KB; Nikota JK; Hu QN; Nguyen A; Wan Y; Lichty BD
    Vaccine; 2018 Apr; 36(16):2181-2192. PubMed ID: 29544689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Specific CD8
    Cáceres-Morgado P; Lladser A
    Methods Mol Biol; 2021; 2197():225-239. PubMed ID: 32827140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.
    Fu R; Qi R; Xiong H; Lei X; Jiang Y; He J; Chen F; Zhang L; Qiu D; Chen Y; Nie M; Guo X; Zhu Y; Zhang J; Yue M; Cao J; Wang G; Que Y; Fang M; Wang Y; Chen Y; Cheng T; Ge S; Zhang J; Yuan Q; Zhang T; Xia N
    Signal Transduct Target Ther; 2024 May; 9(1):118. PubMed ID: 38702343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.
    Yu F; Wang X; Guo ZS; Bartlett DL; Gottschalk SM; Song XT
    Mol Ther; 2014 Jan; 22(1):102-11. PubMed ID: 24135899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model.
    Li X; Wang P; Li H; Du X; Liu M; Huang Q; Wang Y; Wang S
    Clin Cancer Res; 2017 Jan; 23(1):239-249. PubMed ID: 27435398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines.
    Russell SJ; Barber GN
    Cancer Cell; 2018 Apr; 33(4):599-605. PubMed ID: 29634947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.
    McGray AJR; Huang RY; Battaglia S; Eppolito C; Miliotto A; Stephenson KB; Lugade AA; Webster G; Lichty BD; Seshadri M; Kozbor D; Odunsi K
    J Immunother Cancer; 2019 Jul; 7(1):189. PubMed ID: 31315674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
    Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
    Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.